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a b s t r a c t
Our understanding of human papillomavirus (HPV) is still evolving. To further study the ﬁeld, our
laboratory has focused on determining the role of integrins in the initial steps of viral endocytosis into
HaCaT cells. Our and others' previous ﬁndings have shown that α6 is necessary for infection. Here we
show that α3 and β1 were dispensable, and we identiﬁed integrin α6β4 complex as necessary for
infection in HaCaTs. β4 knock down resulted in a signiﬁcant decrease in HPV16 PsV infection and perhaps
most importantly resulted in defective post-translational α6 processing. We showed that the unpro-
cessed α6 does not localize to the cell surface. We propose that the α6β4 complex is necessary for the
formation of an endocytic complex that results in the signaling transduction events necessary for initial
endocytosis.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Papillomaviridae family consists of non-enveloped, 55 nm
diameter, circular dsDNA viruses. To date, more than 150 human
papillomavirus (HPV) types are identiﬁed by DNA sequencing and
these types are commonly divided into ﬁve genera based on
genotyping similarities (Doorbar, 2006; Doorbar et al., 2012).
Infections occur in epithelial cells and can either cause benign
warts on skin and mucosa (low-risk HPVs) or lead to cervical
cancer (Scheffer et al., 2013). Out of the 15 identiﬁed oncogenic
HPV types, HPV16 is the most common etiologic agent associated
with cervical cancer (Laniosz et al., 2009; Schiffman, 2007).
Although this disease-mediating agent has been under study for
more than 40 years, the details of the infection process have not
been clearly identiﬁed.
Research to identify the biological receptor(s) for HPVs has
led to identiﬁcation of some of the key players in HPV infection.
The viral particle consists of the virally encoded L1 and L2 capsid
protein. Many laboratories have shown data supporting that the
initial HPV binding is L1 mediated, and occurs through heparan
sulfate proteoglycans (HSPGs). Data have shown that removing
the heparan sulfate glycosaminoglycans reduces infection; further-
more, addition of a soluble analog of heparan sulfate competes for
HPV binding and thus blocks infection (Abban and Meneses, 2010;
Giroglou et al., 2001; Johnson et al., 2009; Joyce et al., 1999). This
initial binding has been suggested to occur in the extracellular
matrix or at the cell surface. Upon binding of the virus to the
HSPGs, a conformational change occurs. This change has been
shown to be mediated by host cell protein cyclophilin B and
results in the exposure of a hidden N-terminus of L2 (Bienkowska-
Haba et al., 2009). This exposed region of L2 can be cleaved by
members of the proprotein convertase family of peptidases, furin
and/or PC 5/6 (Richards et al., 2006; Seidah and Prat, 2012). The
cleavage of the L2 N-terminus is necessary for infection and is
hypothesized to facilitate the transfer of the virus capsid to a
secondary receptor on the keratinocyte plasma membrane (Day
et al., 2008; Selinka et al., 2007). Search for this secondary receptor
initially led to integrin α6 using HPV6b L1 viral like particles (VLP)
(Evander et al., 1997). Using HPV16 pseudovirions, we conﬁrmed
the initial binding of viral particles to α6 and showed that siRNA-
mediated silencing of integrin α6 decreases infection in HaCaTs
(Abban and Meneses, 2010). In addition to the role of α6 integrin,
the role for tetraspanins has been proposed by Dr. Florin's group;
Dr. Ozbun's group has discussed the presence of an endocytic
complex consisting of HPV16 PsVs, HSPGs and EGF; Annexin A2
and its S100A10 subunit have been identiﬁed as L2-speciﬁc
receptor by Dr. Kast's group and they have further been character-
ized by Dr. Ozbun's group; and most recently Drs. DiMaio and
Atwood's group have suggested the role of a retromer as necessary
for infection and trafﬁcking of incoming virus (Scheffer et al., 2013;
Surviladze et al., 2012; Woodham et al., 2012; Dziduszko and
Ozbun, 2013; Lipovsky et al., 2013).
In the aforementioned studies of Drs. Florin and Ozbun, the two
common molecules seem to be the integrin α6 and tetraspanin
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151 (Scheffer et al., 2013; Surviladze et al., 2012). Integrins are
transmembrane receptors that have no intrinsic catalytic or enzy-
matic activity. To date, 18α and 8β integrin subunits have been
identiﬁed—each of which is a single pass type I transmembrane
protein—making up 24 identiﬁed integrin complexes. Upon ligand
binding, integrins can mediate outside-in signaling with their
ability to transduce signals through proteins that dock on their
cytoplasmic tails, and also by regulating their ligand-binding
afﬁnity they can mediate inside-out signaling events (Takada
et al., 2007). The proposed secondary HPV receptor integrin α6
can form complexes with either β1 or β4 integrins (Kligys et al.,
2012). The possible roles of β subunits as a direct binding partner
of HPV virions during infection were investigated, and these
studies lead to the conclusion that neither β1 nor β4 showed
any direct binding to viral particles (Evander et al., 1997; Huang
and Lambert, 2012; Yoon et al., 2001).
In a previous study, we showed the importance of α6 in infection
and we proﬁled the integrin subunits in human adult keratinocyte
cell line (HaCaT). Our data showed that β1, α2, β2, α3, β4, β6 and α6
were present on HaCaT's cell surface (Abban and Meneses, 2010).
Because integrins function as obligate heteromers, we addressed
what complexes were formed in HaCaTs. We focused on four integrin
subunits based on the proﬁling data: α3, α6, β1 and β4. These
integrins have been implicated in wound healing (Goldﬁnger et al.,
1999; Margadant et al., 2009). We identiﬁed several integrin com-
plexes, and α6β4 was found to be involved in HaCaT infection by
HPV. Our data showed that the level of β4 was directly correlated to
the level of infection and for proper α6 integrin processing.
Results
Assessment of possible integrin complexes on HaCaTs
Integrin function requires a pairing of an α and a β subunit
into a heterodimer. Based on our previous integrin proﬁling we
addressed what heterodimers are found on HaCaTs. Using stan-
dard immunoprecipitation experiments with the α subunits as
bait we showed that α3 was able to pull down β1 but not β4
(Fig. 1A, lanes 6 and 12) while α6 was able to pull down β4 but not
β1 (Fig. 1B, lanes 6 and 9). We conﬁrmed the presence of α6β4 and
the lack of α3β4 complex by the reverse pulldown (Fig. 1C, lanes
8 and 14) These pulldowns showed that integrin complexes α3β1
and α6β4 were formed in HaCaTs.
Integrin β4, but not α3 or β1 are required for HPV16 pseudovirion
infection
Having identiﬁed two heterodimeric integrin complexes, we
tested the biological signiﬁcance of the various integrins. HaCaT
cells were treated with integrin speciﬁc siRNAs, subsequently
incubated with HPV16 pseudovirion, and infection levels assessed
by ﬂow cytometry (GFP pseudogenome 8fwb plasmid was used in
viral particles). The protein level of α3, β1, and β4 were reduced by
81%, 99%, and 96% compared to untreated HaCaTs (Fig. 2 western
blots A, D, G and the measurements B, E, H). The necessity of α6
integrin data have been previously published by our group (Abban
and Meneses, 2010). We did not observe any changes in infection
in either α3 or β1 knockdown cells, but saw a 90% decrease in
infection in β4 knockdown cells. Taken together with our previous
α6 work, these data suggested that the necessary integrin complex
for HPV16 infection in HaCaTs is α6β4.
β4 Integrin is necessary for α6 integrin detection at the cell surface
We used confocal microscopy and ﬂow cytometery to test the
status of α6 and β4 integrins in β4 knockdown cells. As shown in
Fig. 3A, control siRNA treated HaCaT cells have β4 and α6 integrin
staining (Fig. 3A red and green, respectively; Fig. 3C lanes 1–2). By
contrast, the level of α6 is minimal in β4 knock down cells (Fig. 3B
red for β4, green for α6; Fig. 3C lanes 3–4). Flow cytometry
analysis showed that the cell surface levels of β4 and of α6 are
greatly decreased. Fig. 3D and E shows the shift to the left of both
β4 and α6 staining indicative of a decrease in the surface
expression of both integrins (Fig. 3D and E, compare the black
trace-untreated vs. gray-β4 siRNA treated HaCaTs). Data are
presented in graphical form in 3F (black-control cells, gray-
β4siRNA treated cells, isotypic IgG controls were used in these
experiments). These experiments showed that the detectable
levels of both β4 and α6 within cells and at the cell surface is
greatly reduced in β4 knockdown cells.
In β4 knock down HaCaTs, α6 integrin does not form a complex
with β1
The observed decrease in levels of β4 by microscopy and ﬂow
cytometry were consistent with our western blot analysis of β4
knockdown cells. It was surprising to see a comparable loss of α6
expression. Based on the literature, one would theorize that in the
absence of β4, α6 would pair with β1. Unexpectedly, our results
showed that no such compensation occurs. The western blot of β4
knockdown cells clearly showed α6 expression but an immuno-
precipitation with α6 in these samples did not immunoprecipitate
β1 (Fig. 4). Thus, α6 does not complex with β1 in the absence of β4
in these experiments.
α6 processing is affected in the absence of β4 but not in the absence
of β1 or α3 protein
Analysis of α6 on the western blot of the β4 knockdown HaCaTs
showed an α6 band at 140 kDa. This size was inconsistent with a
processed α6 protein. A comparison of lanes 5, 6 to lanes 1–4 in
Fig. 5A (control cells vs. β4 knockdown cells) shows that, in β4
knockdown cells the predominate α6 band detected is 140 kDa as
compared to the 120 kDa band detected in control cells. The data
lead us to conclude that lack of β4 protein results in the loss of α6
processing which results in its inability to be properly express at
the cell surface and thus contributes to the loss in infection. The
level of α6 processing was not disrupted in β1 or α3 knockdown
cells, which did not have a loss of infection (Fig. 5 B and Fig. S4).
α3 siRNA knockdown for experiment in Fig. S4 is shown in Fig. 2A.
These ﬁnal data are supportive although correlative with the
importance of α6 processing.
Discussion
The many improvements in the production of papillomavirus
particles have allowed for a rapid development of data regarding
the process of HPV virus binding, entry, trafﬁcking and thus, onset
of infection. In our laboratory we have taken advantage of the
pseudovirion production technique that results in a viral particle
containing an easily detectable reporter gene/protein, GFP. We
used these pseudovirions to transduce the target cell model
HaCaTs. In a previous work, we sought to determine if the ﬁnding
that HPV16 VLPs bound to α6 integrin meant that α6 integrin was
indeed a biological receptor for HPV16, i.e., absence of α6 integrin
would result in a loss of infection (Evander et al., 1997; Yoon et al.,
2001). We showed that α6 integrin was indeed crucial for HPV16
PsV infection in HaCaT cells (Abban and Meneses, 2010). We also
characterized the integrin subunits that were expressed in HaCaTs
with the thought that perhaps other integrin subunits played a
role in HPV16 infection. We showed that the integrin subunits β1,
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α2, β2, α3, β4, β6 and α6 were expressed in HaCaT cells (Abban
and Meneses, 2010). These data suggested that various integrin
complexes (integrins are obligate heterodimers) could be formed
in HaCaTs using the aforementioned integrins in the format of
αXβY, were X and Y refer to the various subunit numbers (Takada
et al., 2007).
In this manuscript, we addressed if HPV16 infection was depen-
dent on other integrins and examined what beta partners were
necessary for α6s role—as integrins are obligate heterodimers. Our
data showed that in HaCaTs, α6 integrin forms complex with β4
integrin and α3 integrin forms complex with β1 integrin, but we
saw no evidence of β1 interaction with α6 (Fig. 1). Using siRNA, we
individually knocked down α3, β1, and β4 integrins. It is important
to note that these integrins, along with α6, are the most prominently
expressed during the process of wound healing (Goldﬁnger et al.,
1999; Margadant et al., 2009). Data and biology of papillomavirus
infection suggest that infection by HPV is most likely to occur during
the process of wound healing (Roberts et al., 2007). Our experiments
showed that a decrease of over 85% of either α3 or β1 protein did
not negatively impact infection levels (Fig. 2C, F). In contrast, similar
level of β4 integrin knock down showed a 90% decrease in HPV16
PsV infection in HaCaT cells (Fig. 2I).
In the process of performing our experiments, Dr. Florin's group
showed that α3 knock down causes a decrease in HPV16 PsV
infection in HeLa cells (Scheffer et al., 2013). Our results in HaCaT
cells are different from their ﬁnding in HeLa cells; i.e., knock down
of α3 does not decrease HPV16 PsV infection in HaCaT cells
(Fig. 2C).
We previously published the importance of α6 during infection,
and here we showed that it is the partner of β4 in HaCaT cells.
Using an antibody to the surface exposed segment of α6, our ﬂow
cytometry data presented here showed that in addition to a loss of
β4, β4 knock down cells have decreased cell surface α6 integrin
expression (decrease of 75%) (Fig. 3E). β4 integrin depletion did
Fig. 1. Integrin complexes in HaCaTs. (A) HaCaT cell lysate was subjected to immunoprecipitation with integrin α3 antibody. Experiment in lanes 1–6 was analyzed for α3
and β1, experiment in lanes 7–12 was analyzed for α3 and β4. Lane 6 shows coimmunoprecipitation of β1 and α3 integrins, lane 12 shows lack of coimmunoprecipitation of
α3 and β4. (B) HaCaT cell lysate was subjected to immunoprecipitation with integrin α6 antibody (sc-6596). Lanes 1–3 were blotted for α6, lanes 4–6 for β4, and 7–9 for β1
(same membrane was used). Lane 6 shows coimmunoprecipitation of β4 and α6 integrins, whereas lane 9 shows lack of α6β1 complex in HaCaT cells. (C) β4 integrin antibody
was used to perform immunoprecipitation using HaCaT cell lysate. Experiment in lanes 1–8 was analyzed for β4 and α6, experiment in lanes 9–14 was analyzed for β4 and α3.
Lane 8 shows the presence of α6β4 complex in HaCaT cells Lane 14 shows the lack of α3β4 complex in HaCaT cells.
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not interfere with α3 integrin's surface localization (Fig. S1) and
α6 integrin was able to localize to the cell surface in β1 integrin
knock down HaCaTs (Fig. S2). The loss of α6 integrin in the β4
integrin knockdown cell was also observed by microscopy using
an antibody targeting the intracellular portion of α6 (Fig. 3B).
However, in western blots we were able to detect normal levels of
α6 integrin protein in these cells (Fig. 5A). These data suggested
that the epitopes detected by these two in-vivo antibodies under
normal conditions are not properly formed. Data also suggest that
in the absence of β4 there is no compensatory mechanism to
properly process and express α6 at the cell surface. It has been
suggested that in the absence of β4, β1 can serve as heterodimer
partner for α6 (Kligys et al., 2012). Our data showed that β1 did
not compensate for the absence of β4, i.e., no α6β1 complex was
formed in the absence of β4 (Fig. 4A).
Further analysis of our data pointed out that in our immuno-
precipitation western blots, there was an α6 doublet. Integrin α6 is
known to be processed post-translationally, including cleavage, in
order for proper signaling (Delwel et al., 1996). The cleavage of
the 140 kDa proform of α6 results in the production of the heavy
chain (120 kDa) and light chain (20 kDa) that are covalently
associated. In our SDS-PAGE/western blot assays, we observed the
unprocessed proform (140 kDa), and the processed heavy chain
(120 kDa). The presence of these two bands is in agreement with
other groups' studies (Lehmann et al., 1996; Lissitzky et al., 2000).
The relative levels of these two forms differed between normal
and β4 knockdown cells. The control cells had primarily the
processed band (lower), in contrast to cells with β4 knockdown,
the balance shifted to an accumulation of the proform. These data
suggest that in the absence of β4, there is diminished or lack of
α6 processing. In addition to α6, α3 integrin is also known to be
post-translationally processed (Lehmann et al., 1996). Therefore
we also analyzed the effect of β4 knock down on α3 processing. As
opposed to its interference with α6 processing, β4 knock down did
not have a similar effect on α3 processing (Fig. S3). We analyzed
our other integrin knockdown experiments (i.e., α3, β1) for
relative level of α6 processing, and we did not observe a change
as compared to control cells (Fig. 5B and Fig. S4). Our results thus
suggested the inability to have α6 properly processed results in
HPV16 infection loss in HaCaT cells.
It has been previously shown that inhibiting the role of furin
and PC 5/6 results in the loss of HPV16 infection. In HPV biology,
the published data show that the N-terminus of HPV minor capsid
protein L2 is the target for the aforementioned proteases (Richards
et al., 2006). This L2 N-terminus cleavage facilitates transfer of the
virus to a secondary receptor on the basal keratinocyte before its
internalization into cells (Day et al., 2008). It is of interest to point
out that furin and PC 5/6 are also involved in post-translational α
integrin processing (Lissitzky et al., 2000). Studies with inhibitors
of furin-like PCs resulted in a dramatic decrease in papillomavirus
Fig. 2. siRNA-mediated integrin β4 knock down, but not β1 or α3 knock down decreases HPV16 infection. (A) Integrin α3 antibody incubation shows the efﬁcient
integrin α3 knockdown in lanes 5 and 6. Actin was used as the loading control. (B) Measured integrin α3 band intensity of each lane was normalized to corresponding actin
measurements. Integrin α3 protein levels decreased by 80% in α3 siRNA treated cells. (C) HPV16 PsV infection did not decrease in integrin α3 knockdown HaCaTs.
(D) Integrin β1 antibody incubation shows the efﬁcient integrin β1 knockdown in lanes 5 and 6. Actin was used as the loading control. (E) Measured integrin β1 band
intensity of each lane was normalized to corresponding actin measurements. Integrin β1 protein levels decreased by %98 in β1 siRNA treated cells. (F) HPV16 PsV infection
did not decrease in integrin β1 knockdown HaCaTs. (G) Integrin β4 antibody incubation shows the efﬁcient integrin β4 knockdown in lanes 5 and 6. Actin was used as the
loading control. (H) Measured integrin β4 band intensity of each lane was normalized to corresponding actin measurements. Integrin β4 protein levels decreased by %96 in β4
siRNA treated cells. (I) HPV16 PsV infection signiﬁcantly decreased in integrin β4 knockdown HaCaTs. (B), (E), (H): Each bar shows the mean and normalized protein levels of
two samples under each treatment (duplicate experiments). Integrin α3/β1/β4 expression in untreated HaCaT cells was considered as 100%. (C), (F) and (I): Percentage of
infection was determined by ﬂow cytometry. Error bars show the standard deviation of three experiments in which 10,000 cells were analyzed for GFP expression to obtain
the percent of infected cells.
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Fig. 3. siRNA-knockdown of integrin β4 causes loss of integrin α6 surface expression in HaCaT cells. (A, B) Staining for integrin α6 with sc-6596 (green) and integrin β4
with ab-1922 (red) are shown in control siRNA treated and β4 siRNA treated cells. In β4 knock down cells α6 integrin staining was virtually lost. (C) β4 knock down was
conﬁrmed via western blot using the lysates of same control and β4 siRNA treated cells in Fig. 3A and B. (D) Surface expression levels of β4 integrin in untreated cells (black
graph) and β4 siRNA treated cells (gray); IgG isotype staining of β4 siRNA treated HaCaT cells are shown inwhite. (E) Surface expression levels of α6 integrin in untreated cells
(black graph), β4 siRNA treated cells (gray), and IgG isotype staining of β4 siRNA treated HaCaT cells (white) detected by ﬂow cytometer. (F) Bar graph depiction of the mean
ﬂuorescence intensities of β4 and α6 integrins in untreated and β4 knock down cells. IgG isotype stainings of β4 and α6 integrins in β4 knock down cells are shown as well.
P. Aksoy et al. / Virology 449 (2014) 45–52 49
infection (Richards et al., 2006). The effects of those inhibitors on
α6 integrin processing are being addressed in our laboratory in
order to broaden our understanding of the roles of these PCs in
HPV biology.
In summary our study is the ﬁrst to show the roles of integrins
α3, β1 and β4 in HPV16 PsV infection in HaCaT cells. Our results
clearly indicated that, as opposed to its crucial role in HPV16 PsV
infection in HeLa cells, α3 integrin is, in fact, dispensable for
infection in HaCaT cells. β1, the beta partner of α3 is also not
required for HPV16 PsV infection HaCaTs. Based on the data
presented in this manuscript, we articulate that β4 knock down
causes loss of functional integrin α6 from the cell surface; there-
fore, α6 can no longer function as an HPV receptor. Loss of
functional α6 at the cell surface may prevent the formation of
the proposed endocytic complex or may lead to a loss of proper
signal transduction leading to viral entry. Further studies are
ongoing to determine the events mediated by the α6β4 hetero-
dimer and the processing of α6.
Experimental procedures
Cell culture and HPV16 PsV production
HaCaT cells (in vitro spontaneously transformed keratinocytes from
histologically normal skin) were purchased from AddexBio (San Diego,
CA). Cells were cultured in Dulbecco's Modiﬁed Eagle's media (DMEM)
supplemented with 10% Fetal Bovine Serum (FBS, DMEM-10). DMEM
was purchased from Thermo Scientiﬁc (Waltham, MA) and FBS was
purchased from Gemini Bio-products (West Sacramento, CA).
HPV16 pseudovirion (PsV) production and puriﬁcation were
performed as previously described (Abban and Meneses, 2010).
Brieﬂy, 8fwb (GFP expressing plasmid) and p16sheLL (HPV16 L1
and L2 plasmid) were transfected into 293TT cells. Cells were
harvested, and after high salt extraction, PsV were puriﬁed on an
optiprep gradient (27–39%). In our experiments, infection is
detected by the expression of GFP at a multiplicity of infection
(MOI) of 0.15, i.e., 0.15 infectious units/cell using ﬂow cytometer
(BD Accuri C6 ﬂow cytometer, Franklin Lakes, NJ). 293TT cells were
a generous gift from Dr. Ozbun (The University of New Mexico
School of Medicine, NM).
Antibodies
Rabbit ab1922 (anti-integrin β4), rabbit ab1952 (anti-integrin β1),
mouse ab2057 (anti-integrin α3) and rabbit ab1920 (anti-integrin α3)
antibodies were purchased from EMD Millipore (Billerica, MA). Goat
sc-6596 (anti-integrin α6) was purchased from Santa Cruz Biotechno-
logy (Dallas, TX). Integrin α6 rabbit recombinant oligoclonal antibody
Fig. 4. β1 does not compensate as α6 partner in β4 knockdown cells. β4 knock
down HaCaT cell lysate (knock down shown in Fig. 1A) was subjected to
immunoprecipitation with integrin α6 antibody (sc-6596). Lanes 1–3 show α6
integrin antibody incubation and lanes 4–6 show integrin β1 antibody incubation
of the same membrane. Lane 6 indicates the lack of α6-β1 complex in β4 knock
down HaCaT cells.
Fig. 5. Atypical processing of α6 integrin in β4 knockdown cells. (A) Untreated, control siRNA and integrin β4 targeted siRNA treated HaCaT cells lysates were subjected to
western blotting using α6 antibody (β4 and actin incubation results of the same membrane were shown in Fig. 2G). In β4 siRNA treated cells, the enrichment of integrin α6
proform (140 kDa) over processed α6 (120 kDa) occurred. (B) Integrin β1 antibody incubation shows the efﬁcient integrin β1 knockdown in lanes 5 and 6 (WB: β1). The same
set of cell lysates were used for α6 antibody incubation. Actin was used as the loading control for both western blots. In α6 antibody incubation, there was no enrichment of
integrin α6 proform (140 kDa) over processed α6 (120 kDa) in β1 knock down cells.
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(Cat. no. 710209) was purchased from Novex-Life Technologies (Grand
Island, NY).
siRNA-mediated knock down of integrins β4, β1 and α3
Accell SMARTpools (set of 4 siRNAs) were purchased from
Dharmacon (Waltham, MA). Lipofectamine RNAiMax was pur-
chased from Life Technologies (Norwalk, CT). Negative control
siRNA was purchased from IDT (Coralville, IA) (sense: CGUUAA-
UCGCGUAUAAUACGCGUAT, antisense: AUACGCGUAUUAUACGC-
GAUUAACGAC). HaCaT cells were plated on 12-well plates, at
60% conﬂuency; cells were transfected with 2 μl lipofectamine
and 40 nM of Accell SMARTpool for integrin β4, 2 μl lipofectamine
and 20 nM of Accell SMARTpool for integrin β1, and 2 μl lipofec-
tamine and 20 nM of Accell SMARTpool for integrin α3. Cells were
harvested at 24 h post-transfection with α3 siRNA pool and at 48 h
for integrin β1 and β4 siRNA pools with the following lysis buffer:
Nonidet P-40 (United States Biological, Salem, MA) and 50
protease inhibitor cocktail (BD Biosciences, San Jose, CA). The cell
lysates were then subjected to western blot analysis. After western
blot transfer, the nitrocellulose membrane (Thermo Scientiﬁc) was
blocked for 30 min with 5% milk and incubated overnight with
corresponding primary antibodies. Odyssey Imaging System (Li-
Cor, Lincoln, NE) was used to scan the membrane and the band
intensities were analyzed using the built-in software.
HPV16 PsV infection of HaCaT cells and ﬂow cytometry analysis
After siRNA-mediated knock down of aforementioned integrin
subunits was achieved, the cells were incubated on ice for 30 min
in fresh DMEM-10. The cells were then infected with HPV16 PsV at
an MOI of 0.15 and incubated on ice for 2 h. After 2 h, media was
removed and the cells were washed three times with 1 PBS.
Infected cells were incubated for 48 h at 37 1C. The cells were then
collected via trypsinization and they were washed three times
with 1 PBS (MP biomedicals, Solon, OH) by spinning at 3000 g
for 5 min. Percentage of infected HaCaT cells was calculated based
on GFP positive cells that were measured by ﬂow cytometer.
Co-immunoprecipitation experiments
HaCaT cells were plated on 100 mm tissue culture dishes and at
80% conﬂuency, the cell lysates were harvested in NP40 and 50
protease inhibitor mix. α6, β4, β1 and α3 integrins were immu-
noprecipitated with protein A and protein G magnetic beads (EMD
Millipore) and α6, β4 and α3 antibodies according to the manu-
facturer's instructions. HaCaT cell lysate that was not subjected to
IP is referred as pre-IP; cell lysate that was incubated with
magnetic beads for 1 h in the absence of corresponding antibodies,
(before antibody was added) is referred as pre-clear.
Immunoﬂuorescence experiments
To visualize integrin α6 and β4 subunits in β4 knock down and
control siRNA treated HaCaT cells, the cells were plated on 12-well
plates containing glass coverslips. Knock down of integrin β4 was
performed with siRNA transfection and negative control siRNA
was used for control siRNA treated cells (as described above).
At 48 h post-transfection, media was aspirated and cells were
washed three times with 1 PBS. The cells were then ﬁxed in 4%
paraformaldehyde for 10 min on ice and washed three times with
1 PBS. Cells on coverslips were permeabilized using blocking
buffer (0.2% ﬁsh skin gelatin (Sigma, St. Louis, MO), 0.2% Triton X-
100 in PBS) for 15 min at room temperature. The coverslips were
then incubated with corresponding primary antibodies (integrin
α6:sc-6596, and integrin β4: ab-1922) at a dilution of 1:50 for 1 h.
After primary antibody incubation, coverslips were washed three
times with 1 PBS and incubated with secondary antibodies
(Alexa-Fluor donkey anti-rabbit 647 and donkey anti-goat 488) at
1:2000 dilutions for 30 min. Antibody dilutions were prepared in
blocking buffer. After secondary antibody incubation, the cover-
slips were washed three times with 1 PBS and mounted on
slides using ProLong Gold Antifade Reagent.
Detection of integrin α6 and β4 surface level expressions with ﬂow
cytometer
HaCaT cells were seeded on two 12-well plates. siRNA-
mediated knock down of integrin β4 was performed on one of
the plates. Media was aspirated from the wells and the cells were
washed three times with 1 PBS. After that, the cells were
harvested by trypsinization and they were washed three times
with 1 PBS by spinning at 3000 g for 5 min. Following the
washing steps, α6 integrin was stained with PE-Cy 5 Rat anti-
human antibody CD49f (BD Biosciences) and β4 integrin was
stained with PE Rat anti-human CD104 (BD Biosciences). IgG2a
PE-Cy 5 Rat anti-human isotype and IgG2b PE Rat anti-human
isotype antibodies were used as controls for non-speciﬁc ﬂuores-
cence. The cells were incubated with corresponding antibodies for
30 min at 4 1C. Then the cells were washed three times with 1
PBS by spinning at 3000 g for 5 min. Surface expression levels of
α6 and β4 integrins were monitored via ﬂow cytometry analysis
(BD Accuri C6 ﬂow cytometer).
Author summary
Human papillomavirus (HPV) is a major cancer causing agent
worldwide. Infection by HPV can lead to cancers including cervical,
anal, and oropharyngeal. Although much is known about the virus,
there are still questions as to the process by which the virus gains
entry into the target cells, i.e., how does the virus infection ﬁrst
begins. Our research laboratory is working at trying to identify
how the virus ﬁrst attaches to the target cells, and how this leads
to the process of the virus entering the cell. Preventing viral entry
would decrease the level of HPV mediated diseases including
cancers. Here, using a skin cell line we deﬁned cellular molecules
that are involved in the initial viral entry and show that proper
cellular processing of one of these is necessary. Our studies
provide new avenues for viral interference, and show the impor-
tance of protein processing in the expression of viral binding
partners.
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